Partnership expanded to include vascular trauma repair outside of the United States. Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction. Durham, N.C. – June 11, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing […]
Humacyte Expands Strategic Global Partnership with Fresenius Medical Care Read More »
Durham, N.C. – June 4, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7
Humacyte to Provide Investor Update on June 7 Read More »
™ Indicates a trademark of Humacyte Global, Inc.
© 2023 Humacyte Global, Inc. All Rights Reserved. | Sitemap
™ Indicates a trademark of Humacyte Global, Inc.
© 2023 Humacyte Global, Inc. All Rights Reserved.
